Brought to you by 
Histogenics raises $9mm in Series B to fund clinical trials
02 Jun 2011
Executive Summary
Histogenics (developing products to help the body regenerate cartilage) raised $9mm in its Series B financing led by Boston Millennia Partners. Returning shareholders Foundation Medical Partners, Altima Partners, Inflection Point Partners, Stryker, and a private investor also participated.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Histogenics raises $9mm in Series B to fund clinical trials
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice